ATECTURA
LIVE

Serial Number

79245745

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Oct 12, 2018

Add to watchlist:

No watchlists yet
View on USPTO

ATECTURA Trademark

Serial Number: 79245745 • Registration: 5809457

ATECTURA is a trademark filed by NOVARTIS AG on October 12, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,174 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

October 12, 2018

Registration Date

July 23, 2019

Published for Opposition

May 7, 2019

Cancellation Date

February 6, 2026

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

CANCELLED SECTION 71
Feb 6, 2026 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jul 23, 2024 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 6, 2019 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Nov 19, 2019 FICS
FINAL DISPOSITION PROCESSED
Nov 19, 2019 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 23, 2019 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 23, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 7, 2019 NPUB
PUBLISHED FOR OPPOSITION
May 7, 2019 PUBO
NOTIFICATION PROCESSED BY IB
May 3, 2019 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 17, 2019 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 17, 2019 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 17, 2019 OP2R
WITHDRAWN FROM PUB - OG REVIEW QUERY
Mar 26, 2019 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 8, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 8, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 8, 2019 CRFA
ASSIGNED TO LIE
Mar 6, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 4, 2019 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 25, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 25, 2019 REAP
REFUSAL PROCESSED BY IB
Feb 2, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 17, 2019 RFCS
REFUSAL PROCESSED BY MPU
Jan 17, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 8, 2019 RFCR
NON-FINAL ACTION WRITTEN
Jan 7, 2019 CNRT
ASSIGNED TO EXAMINER
Dec 31, 2018 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 7, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 3, 2018 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Nov 30, 2018 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 22, 2018 REPR